What Potential Role is There for Medication Treatment in Anorexia Nervosa?

被引:39
|
作者
Crow, Scott J. [1 ]
Mitchell, James E. [2 ,3 ]
Roerig, James D. [2 ,3 ]
Steffen, Kristine [2 ,3 ]
机构
[1] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA
[2] Neuropsychiat Res Inst, Fargo, ND USA
[3] N Dakota State Univ, Sch Med & Hlth Sci, Fargo, ND 58105 USA
关键词
anorexia nervosa; medication; antidepressant; antipsychotic; 5-HT2A RECEPTOR-BINDING; SHORT-TERM TREATMENT; DOUBLE-BLIND; OLANZAPINE TREATMENT; CONTROLLED-TRIAL; RESTRICTING-TYPE; ADJUNCTIVE FLUOXETINE; INPATIENT TREATMENT; WEIGHT RESTORATION; EATING DISORDERS;
D O I
10.1002/eat.20576
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: To review selected issues regarding the development of drug treatments for anorexia nervosa (AN). Method: The existing pharmacotherapy literature for AN is reviewed, and the theoretical and practical considerations are discussed. Results: A very wide variety of drugs have been examined in AN, generally with negative results. There are a number of potential reasons for this finding, including compliance, nutritional deficits, selection of the wrong targets or the wrong outcome measures, use of monotherapy, lack of animal models, or factors intrinsic to AN. Conclusion: Pharmacotherapy provides little benefit in the treatment of AN at present, Several strategies might lead to the identification of more effective agents, including new measurement strategies, identification of novel pharmacologic targets, and consideration of a clinical trials network. (C) 2008 by Wiley Periodicals, Inc.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] What is the role of pharmacotherapy in the treatment of anorexia nervosa?
    Israël, M
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2005, 30 (06): : 464 - 464
  • [2] Quetiapine: A potential treatment of anorexia nervosa
    Petric, D
    Graovac, M
    Franciskovic, T
    Kastelan, A
    Moro, LJ
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S620 - S620
  • [3] Microbiota in anorexia nervosa: potential for treatment
    Landini, Linda
    Dadson, Prince
    Gallo, Fabrizio
    Honka, Miikka-Juhani
    Cena, Hellas
    [J]. NUTRITION RESEARCH REVIEWS, 2023, 36 (02) : 372 - 391
  • [4] Surgical treatment of medication-resistant anorexia nervosa
    Torres Diaz, Cristina V.
    Martin Pena, Gonzalo
    Ezquiaga, Elena
    Navas Garcia, Marta
    Garcia de Sola, Rafael
    [J]. NUTRICION HOSPITALARIA, 2016, 33 (04) : 1001 - 1007
  • [5] Is there a role for pharmacogenetics in the treatment of anorexia nervosa?
    Smith, Sarah
    Woodside, Blake
    [J]. PHARMACOGENOMICS, 2016, 17 (13) : 1381 - 1383
  • [6] The role of olanzapine in the treatment of anorexia nervosa
    Dunican, Kaelen C.
    DelDotto, Dana
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (01) : 111 - 115
  • [7] What is the role of ghrelin and orexin A (OXA) in anorexia nervosa (AN)?
    Matuszczyk, MM
    Janas-Kozik, M
    Krupka-Matuszczyk, IZ
    Wilczok, T
    Mazurek, U
    Kasperczyk, J
    Sypniewski, D
    Augustyniak, E
    Soowiów, R
    Szymszal, J
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S293 - S293
  • [8] EMOTIONAL PROCESSING IN ANOREXIA NERVOSA - WHAT IS THE ROLE OF NEUROMODULATION?
    Ramos, C. Pinheiro
    Vaz, A. R.
    Sampaio, A.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S523 - S524
  • [9] THE INTERNISTS ROLE IN THE SUCCESSFUL TREATMENT OF ANOREXIA NERVOSA
    GIFFIN, ME
    FRAZIER, SH
    ROBINSON, DB
    JOHNSON, AM
    [J]. PROCEEDINGS OF THE STAFF MEETINGS OF THE MAYO CLINIC, 1957, 32 (08): : 171 - 182
  • [10] ROLE OF FAMILY IN TREATMENT OF ANOREXIA-NERVOSA
    LIEBMAN, R
    MINUCHIN, S
    BAKER, L
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1974, 13 (02): : 264 - 274